EA
60
-5
PVH
60
-4
VRTX
47
-6
EXC
54
3
LUV
45
-2
IFF
47
-4
BMY
55
-8
ROST
57
-3
RSG
65
-3
HRL
35
-3
EXR
57
2
XOM
42
-6
ICE
59
-3
KO
38
-3
DVN
14
-6
WDC
37
-3
AMAT
33
-13
M
31
-3
TRIP
50
-4
VZ
44
4
EA
60
-5
PVH
60
-4
VRTX
47
-6
EXC
54
3
LUV
45
-2
IFF
47
-4
BMY
55
-8
ROST
57
-3
RSG
65
-3
HRL
35
-3
EXR
57
2
XOM
42
-6
ICE
59
-3
KO
38
-3
DVN
14
-6
WDC
37
-3
AMAT
33
-13
M
31
-3
TRIP
50
-4
VZ
44
4
Financhill
Back

Clearside Biomedical 10K Form

Sell
20

CLSD
Clearside Biomedical

Last Price:
0.99
Seasonality Move:
25.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLSD News And Ratings

See the #1 stock for the next 7 days that we like better than CLSD

CLSD Financial Statistics

Sales & Book Value

Annual Sales: $8.23M
Cash Flow: $-6.1M
Price / Cash Flow: 0
Annual Sales: $-0.38
Price / Book: 0

Profitability

EPS (TTM): -0.50000
Net Income (TTM): $-33.46M
Gross Margin: $7.87M
Return on Equity: 0%
Return on Assets: -92.06%

Clearside Biomedical Earnings Forecast

Key Clearside Biomedical Financial Ratios

  • The Gross Profit Margin over the past 5 years for CLSD is 95.68%.
  • The Selling, General & Administrative Expenses for CLSD have been equal to 144.29% of Gross Profit Margin.
  • The Research & Development expenses have been 253.42% of Revenue.
  • The Interest Expense is -28.81% of Operating Income.
  • The Net Earning history of CLSD is -394.91% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 4 years.

Clearside Biomedical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CLSD
CUSIP: 185063
Website: clearsidebio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.07
Quick Ratio: 5

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CLSD Technical Analysis vs Fundamental Analysis

Sell
20
Clearside Biomedical (CLSD) is a Sell

Is Clearside Biomedical a Buy or a Sell?